Medication info
Pevarejet Tablet 2/10 mg

Pevarejet Tablet 2/10 mg

Prescription medicationTabletOral
Ingredient · strength
Pitavastatin Calcium›2mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Ahn Gook Pharmaceutical Co., Ltd.
Appearance
Yellow oval film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202301662 · Approved 2023.05.24 · Insurance code 650206040

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This drug is administered once daily, with or without food. Patients should follow a standard cholesterol-lowering diet continuously before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4/10mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Administration in patients with hepatic impairment: Since the recommended initial dose of pitavastatin calcium in patients with hepatic impairment is 1 milligram daily, use of this drug (pitavastatin calcium/ezetimibe combination) for initial treatment is not recommended. The maximum dose is 2/10mg daily. Use of this drug (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this drug (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Ingredients

Manufacturer
Ahn Gook Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL cholesterol
View approved original text

This medication is used in patients with primary hypercholesterolemia, particularly in heterozygous familial and non-familial hypercholesterolemia, or mixed dyslipidemia. It helps reduce elevated total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels. Additionally, it increases HDL cholesterol levels, known as good cholesterol, improving the blood lipid profile. This medication serves as a supplement to diet in regulating blood lipid levels and reducing the risk of cardiovascular disease. Therefore, it is effectively used in the treatment of dyslipidemia.

How to take

Adult dose

This drug is administered once daily, with or without food. Patients should follow a standard cholesterol-lowering diet continuously before and during treatment with this drug. The dose of this drug should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. The recommended initial dose is 2/10mg once daily. If the LDL cholesterol-lowering effect is insufficient, the dose may be increased to a maximum of 4/10mg daily. Adjust the dose as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response. Patients taking pitavastatin calcium and ezetimibe concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Administration in patients with hepatic impairment: Since the recommended initial dose of pitavastatin calcium in patients with hepatic impairment is 1 milligram daily, use of this drug (pitavastatin calcium/ezetimibe combination) for initial treatment is not recommended. The maximum dose is 2/10mg daily. Use of this drug (pitavastatin calcium/ezetimibe combination) is not recommended in patients with moderate hepatic impairment. Do not administer this drug (pitavastatin calcium/ezetimibe combination) to patients with severe hepatic impairment.

Precautions

This medication should not be used in certain patients. For example, it should not be administered to those with an allergy to its components, patients with severe liver disease, pregnant or nursing women, and children. Patients with impaired liver function or those who consume alcohol excessively should use this medication cautiously, especially patients with poor kidney function also require caution. Furthermore, patients with myopathy or symptoms of muscle weakness and the elderly should be careful when administered. While taking this medication, symptoms such as muscle pain, weakness, and fatigue may appear, so if these symptoms occur, a doctor should be consulted immediately. Regular liver function tests should be done as liver function abnormalities may occur, and if liver enzyme levels rise, the medication may need to be discontinued. This medication can interact with other drugs, so especially when taken with cyclosporine, fibrate drugs, niacin, and certain antibiotics, patients should follow the doctor’s instructions and report any symptoms of muscle pain or worsening kidney function immediately. Pregnant women or women who may become pregnant, as well as nursing mothers, should not use this medication, and if taken during pregnancy, it should be stopped immediately and a doctor consulted. Safety has not been established for use in children, and the elderly should be cautious as the potential for adverse reactions may be higher. In case of overdose, there is no specific antidote, so treatment should be symptomatic and supportive therapy should be provided while monitoring liver function and muscle enzyme levels. This medication should be stored out of the reach of children and not transferred to another container.

Side effects

  • Abdominal pain
  • diarrhea
  • dry mouth
  • bloating
  • gastroesophageal reflux disease
  • toothache
  • increased serum creatine phosphokinase
  • increased alanine aminotransferase
  • increased aspartate aminotransferase
  • weakness
Show 108 more
  • chest discomfort
  • fatigue
  • myalgia
  • altered taste
  • headache
  • urticaria
  • dizziness
  • decreased appetite
  • insomnia
  • shortness of breath
  • lethargy
  • rash
  • itching
  • thrombocytopenia
  • elevated bilirubin
  • increased cholinesterase
  • stiffness
  • drowsiness
  • paralysis
  • vertigo
  • thirst
  • indigestion
  • abdominal distension
  • constipation
  • stomatitis
  • vomiting
  • anorexia
  • glossitis
  • thrombocytopenia
  • neutropenia
  • leukopenia
  • eosinophilia
  • leukocytosis
  • increased globulin
  • anemia
  • polyuria
  • elevated BUN
  • elevated serum creatinine
  • decreased aldosterone
  • increased aldosterone
  • increased adrenocorticotropic hormone
  • increased cortisol
  • decreased testosterone
  • muscle cramps
  • elevated myoglobin
  • palpitations
  • skin pain
  • burning sensation
  • arthralgia
  • edema
  • blurred vision
  • photophobia
  • hearing loss
  • hematuria
  • elevated uric acid level
  • increased serum potassium and phosphorus
  • hair loss
  • sleep disturbances
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • diabetes
  • immune-mediated necrotizing myopathy
  • facial edema
  • arm swelling
  • hypersensitivity
  • skin tingling
  • elevated blood pressure
  • chest discomfort
  • upper respiratory infection
  • pharyngitis
  • sinusitis
  • cough
  • arthralgia
  • low back pain
  • nausea
  • cholelithiasis
  • cholecystitis
  • anaphylaxis
  • rash
  • angioedema
  • erythema multiforme
  • pancreatitis
  • tremors
  • epigastric pain
  • xerostomia
  • epigastric discomfort
  • belching
  • gastrointestinal disorders
  • tongue disease
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • sputum
  • rhinorrhea
  • limb pain
  • hypoglycemia
  • anemia
  • splenomegaly
  • hyperhidrosis
  • conjunctival congestion
  • renal failure
  • abnormal liver function
  • increased serum creatinine
  • increased blood urea nitrogen
  • abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that blocks light and air, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius. Therefore, it should be kept away from direct sunlight and in a place that is neither too hot nor too cold.

Appearance and packaging

Appearance

Yellow oval film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.